Summary

Report Summary

Novonesis Group Strategic SWOT Analysis and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report is a comprehensive and easily accessible overview of Novonesis Group's business operations. It provides a detailed analysis of the company's financial and strategic standing, as well as its position in the industry compared to competitors. The report includes several key features to facilitate decision-making and provide insights into the company's performance.

The report begins with in-depth information about Novonesis Group including key insights, business segments, key executives, locations, products and services, historical events, corporate strategy, and management discussions. This section provides a solid foundation for understanding the company's key attributes.

Next, the report assesses Novonesis Group's strategic standing through various analyses. The ESG spotlight evaluates the company's environmental, social, and governance performance, providing insights into its sustainability efforts and ethical practices. The SWOT analysis examines the company's internal strengths and weaknesses, as well as external opportunities and threats. Additionally, By integrating these strategic analyses, the report offers a comprehensive understanding of Novonesis Group's overall strategic standing and supports informed decision-making and strategic planning.

The report also covers Novonesis Group's financial analysis basis of latest income statement, balance sheet, and cash flow statement. Key financial ratios related to profitability, asset turnover, credit, market, and long-term solvency are outlined, providing guidance for investment decisions. Furthermore, the report compares Novonesis Group's financial parameters with those of its competitors, offering a unique analysis of the competitive landscape. This information helps manage the business environment and improve sales activities by gaining insight into competitors' operations.

Finally, the report includes recent news and deal activities undertaken by Novonesis Group enhancing awareness of the company's business trends, growth perspectives, and more.

Key Highlights

Novonesis Group was established in 2024 following the successful merger of Novozymes and Chr. Hansen, two globally recognized leaders in bioscience and biotechnology. The statutory combination was completed after all regulatory approvals, creating a new company headquartered in Copenhagen, Denmark. Built on more than a century of combined scientific innovation, Novonesis was formed to lead the next era of biosolutions that support better business outcomes, healthier lives, and a healthier planet. The group has a strong global footprint, employing more than 10,000 people worldwide and operating across over 45 countries. Novonesis serves more than 30 industries through a broad portfolio of biosolutions and operates more than 30 production sites, supported by an extensive global network of research, development, and application centers. This scale enables the company to deliver localized solutions while leveraging global scientific capabilities. Novonesis is organized into two core business divisions. Food and Health Biosolutions focus on food and beverages and human health, supporting nutrition, food quality, and wellbeing. Planetary Health Biosolutions address agriculture, energy, technology, and household care, aiming to reduce chemical use, emissions, and resource intensity. The group reported revenue of EUR 3,833.5 million, positioning Novonesis as a leading global biosolutions partner.

Novonesis Group in the News:-

2026-06-11 - Rovensa Next to distribute Novonesis' biosolutions for Plant Health in the United States
2026-05-26 - Full label registration of Novonesis' HiPhoriusTM phytase enables wider use for feed producers in the EU
2026-05-13 - Novonesis becomes a bluesign System Partner, reinforcing sustainable innovation in textiles and leather
2026-04-29 - Novonesis launches Europe's first Bacillus probiotic for dairy cows
2026-04-08 - Novonesis expands global footprint with acquisition of production facility in Southeast Asia


Scope

• Tactical Analysis:- Various strategic frameworks to gain insights into a Novonesis Group's competitive position and operational environment. These analytical tools assist in identifying competitive advantages, potential risks, and areas for improvement and efficiency, enabling companies to make informed tactical decisions.
• Business Strategy:- Contributes to shaping the Novonesis Group's overall direction, goals, and decision-making processes, ensuring long-term success and alignment with stakeholder expectations.
• Financial Position:- Provide valuable information on the financial performance and investor sentiment surrounding the company. Indicating the level of confidence and expectations in the company's future prospects. These components collectively contribute to understanding the financial health and market perception of the company.
• Company Fundamentals:- These fundamentals offer valuable insights into the company's history, operations, leadership, and geographical presence, aiding in a comprehensive understanding of the organization.
• Competitive Landscape:- An identification of the Novonesis Group's main competitors, providing insights into the competitive landscape it operates in.

Reasons to Buy

• Comprehensive Understanding of the Novonesis Group's internal and external factors through SWOT analysis, Financial Analysis, and Competitors Benchmarking.
• Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers.
• Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations.
• Competitive Benchmarking will help to gain a competitive advantage by understanding industry trends, customer preferences, and best practices.
• Financial Performance Evaluation provides crucial insights into key financial ratios and trends, supporting better financial decision-making and resource allocation.
• Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.

Additionally, available deep-dive analysis on the company Novonesis Group:

• Novonesis Group PESTLE Analysis
• Novonesis Group Value Chain Analysis
• Novonesis Group Porter's Five Forces Analysis
• Novonesis Group VRIO Analysis
• Novonesis Group BCG Analysis
• Novonesis Group Segmentation, Targeting and Positioning (STP) Analysis
• Novonesis Group Ansoff Matrix Analysis

ページTOPに戻る

Table of Contents

Table of Contents 2
Tables 6
Charts 7
Novonesis Group - Key Company Facts 8
Novonesis Group - Company Description 9
Novonesis Group - Top Executives 10
Novonesis Group - Top Executives Biographies 11
Novonesis Group - Head Office & Locations 13
Head Office - Country 13
Key Subsidiaries 14
Key Joint Ventures 15
Novonesis Group - Products and Services 16
Products 16
Services 17
Novonesis Group - Historic Events 19
Novonesis Group - Corporate Strategy 23
Novonesis Group - Business Description 27
Food & Health Biosolutions 27
Planetary Health Biosolutions 28
Novonesis Group - ESG Spotlight 29
Environment 29
Social 30
Corporate Governance 31
Novonesis Group - SWOT Analysis 32
Overview 32
Strengths 34
Weaknesses 35
Opportunities 37
Threats 40
Novonesis Group - Financial Deep Dive 42
Share Price Trend - Jun-2025 to Jun-2026 (Average Share Closing Price) 42
Profit and Loss Statement 44
Summary of Profit and Loss Statement 44
Balance Sheet 48
Summary of Balance Sheet 48
Cash Flow Statement 52
Summary of Cash Flow Statement 52
Key Financial Ratio Analysis 56
Novonesis Group - Ratio Charts 58
Activity Ratio Charts 58
Growth Ratios Charts 59
Leverage Ratio Charts 63
Liquidity Ratio Charts 65
Profitability Ratio Charts 67
Competing Players 69
Snapshot of Competing Players 70
Corbion NV 70
Key Company Facts 70
Company Description 70
Key Financials 71
Share Price Trend - Jun-2025 to Jun-2026 (Average Share Closing Price) 71
Key Financial Ratio Analysis 76
International Flavors & Fragrances Inc 78
Key Company Facts 78
Company Description 78
International Flavors & Fragrances Inc. - SWOT Spotlight 79
Key Financials 81
Share Price Trend - Jun-2025 to Jun-2026 (Average Share Closing Price) 81
Key Financial Ratio Analysis 86
Kerry Group plc 88
Key Company Facts 88
Company Description 88
Key Financials 89
Share Price Trend - Jun-2025 to Jun-2026 (Average Share Closing Price) 89
Key Financial Ratio Analysis 94
Sensient Technologies Corporation 96
Key Company Facts 96
Company Description 96
Key Financials 97
Share Price Trend - Jun-2025 to Jun-2026 (Average Share Closing Price) 97
Key Financial Ratio Analysis 102
DSM B.V 104
Key Company Facts 104
Company Description 104
Novonesis Group - In the News 105
26-May-2026 - Full label registration of Novonesis' HiPhoriusTM phytase enables wider use for feed producers in the EU 105
13-May-2026 - Novonesis becomes a bluesign System Partner, reinforcing sustainable innovation in textiles and leather 106
29-Apr-2026 - Novonesis launches Europe's first Bacillus probiotic for dairy cows 108
08-Apr-2026 - Novonesis expands global footprint with acquisition of production facility in Southeast Asia 109
13-Mar-2026 - Novonesis issues EUR 1.7 billion in bonds to refinance bridge facility 110
08-Sep-2025 - Novonesis and Novo Nordisk will explore new solutions to improve metabolic health 111
20-Aug-2025 - 2030 financial targets announced: Organic sales growth acceleration, margin expansion and ROIC improvement 113
08-Jul-2025 - New landmark scientific review on the BB-12 probiotic strain published 116
Novonesis Group - Key Deals 118
23-Oct-2025 - Noma and Novonesis partner to scale deliciousness 118
11-Feb-2025 - Novonesis to acquire dsm-firmenich’s share of the Feed Enzyme Alliance 120
Appendix 122
Definitions 122
SWOT Analysis 122
PESTLE Analysis 122
Value Chain Analysis 122
ESG Spotlight 122
Financial Deep Dive 122
Financial Ratios 123
Activity Ratios 123
Growth Ratios 125
Leverage Ratios 128
Liquidity Ratios 130
Market Ratios 132
Profitability Ratios 134
Research Methodology 136
Disclaimer 137
Contact Us 137